Clinical Research Directory
Browse clinical research sites, groups, and studies.
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
Sponsor: Phoenix Children's Hospital
Summary
The proposed study will be a prospective, randomized, double blind, placebo controlled trial to compare the use of a continuous infusion versus intermittent ketorolac on postoperative patients in the pediatric cardiovascular ICU. We intend to determine if the continuous infusion leads to a decreased utilization of opiates when compared to intermittent ketorolac.
Official title: Continuous Infusion Versus Intermittent Ketorolac for Postoperative Pain Control in Pediatric Cardiac Surgery Patients
Key Details
Gender
All
Age Range
3 Months - 59 Months
Study Type
INTERVENTIONAL
Enrollment
166
Start Date
2021-03-01
Completion Date
2026-12-01
Last Updated
2026-01-23
Healthy Volunteers
No
Conditions
Interventions
Continuous ketorolac
Patients randomized for the treatment arm of the study group will receive a continuous infusion of ketorolac plus an intermittent dose of placebo (plasmalyte) for 48 hours.
Locations (1)
Phoenix Children's Hospital
Phoenix, Arizona, United States